Jun 13, 2024, 00:31 by Molly McGrath

On June 10th, the Michigan Society of Addiction Medicine (MISAM) sent a comment letter to the Michigan Department of Health and Human Services regarding a proposed policy expanding the services provided by Substance Use Disorder (SUD) Health Homes. Specifically, this proposal would add simulant use disorder and alcohol use disorder as eligible diagnoses for reimbursement.

Jun 7, 2024, 14:15 by Kelly Corredor

Sign-on letter to CMS requests more information and transparency on network adequacy, reimbursement rates and practices, utilization management, cost-sharing, and supplemental benefits.

Jun 7, 2024, 14:07 by Molly McGrath

ASAM signed a letter spearheaded by the Campaign for Tobacco-Free Kids, sent to the leadership of the House Appropriations Committee, urging their approval of the full authorized level of tobacco user fees, and their opposition any efforts to weaken or alter the Food and Drug Administration's authority over tobacco products in the appropriations process.

Jun 6, 2024, 17:46 by Kelly Corredor

New ASAM resource on Medicare coverage of injectable addiction treatment medications.

Jun 3, 2024, 22:29 by Molly McGrath

The recent article “Has Fentanyl Peaked?” in The New York Times had me asking a different question: How much do we care about Americans with addiction, dying at unprecedented numbers from an increasingly lethal drug supply?

May 28, 2024, 16:33 by Molly McGrath

A group of over fifty stakeholders and leaders called on the Biden Administration to rescind a $75 'cap' per patient per budget year on incentives in contingency management for treating stimulant use disorder (StimUD).

May 28, 2024, 15:02 by ASAM Weekly Editors

Rapid Initiation of Injection Naltrexone for Opioid Use Disorder

May 22, 2024, 15:14 by Molly McGrath

On May 17th, Louisiana Society of Addiction Medicine (LASAM) sent a letter of opposition to SB 276 ahead of its consideration by the Louisiana House of Representatives. SB 276 would designate mifepristone as a controlled substance.

May 22, 2024, 08:50 by ASAM Weekly Editors

Burden of Mental Disorders and Suicide Attributable to Childhood Maltreatment

May 17, 2024, 07:29 by Molly McGrath

On May 14th, the Louisiana Society of Addiction Medicine (LASAM) sent a letter supporting SB 190 that would raise Medicaid reimbursement rates for physician services, including substance use disorder (SUD) treatment, to members of the House Committee on Health and Welfare.

May 15, 2024, 09:08 by Molly McGrath

The letter asks Congress to fund the SUD Treatment and Recovery Loan Repayment Program (STAR-LRP) at $50 million, and the Addiction Medicine Fellowship (AMF) Program at $30 million, in Fiscal Year 2025.

May 15, 2024, 08:08 by Molly McGrath

The Colorado Society of Addiction Medicine (COSAM) sent a letter to members of the Pueblo City Council opposing a proposed ordinance banning the operation of syringe service programs (SSPs),

May 14, 2024, 14:52 by ASAM Weekly Editors

Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior

May 10, 2024, 12:37 by Kelly Corredor

Doctors and Pharmacists groups send letter to federal agencies to highlight buprenorphine access issues in pharmacies and to request clear guidance to ensure patients can get their medications.

May 8, 2024, 12:51 by Kelly Corredor

A new proposed rule from CMS will implement 200 new Medicare-funded residencies and fellowships in 2026.

May 7, 2024, 15:48 by ASAM Weekly Editors

Biomarkers of metal exposure in adolescent e-cigarette users: correlations with vaping frequency and flavouring

May 7, 2024, 09:23 by Molly McGrath

AMAC-registered ASAM members can submit a resolution by August 23 at 5:00pm ET, for circulation by pamphlet to AMAC-registrants on September 9, and consideration by all AMAC attendees on September 23-24 in Washington, DC.

May 6, 2024, 22:56 by Molly McGrath

Members of the U.S. House of Representatives in Congress wrote a bipartisan Dear Colleague letter, sent to the Chairman and Ranking Member of the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, that urged increased funding for two critical substance use disorder (SUD) workforce programs, the SUD Treatment and Recovery Loan Repayment Program (STAR-LRP), and the Addiction Medicine Fellowship (AMF) Program.

May 6, 2024, 15:33 by Christopher M. Jones, PharmD, DrPH, MPH

The United States is in the midst of an evolving and dynamic overdose crisis, driven by the proliferation of fake pills that contain illicitly made fentanyl and other synthetic opioids. Recently released data from the Centers for Disease Control and Prevention (CDC) show more than 107,000 lives lost to overdose in 2022 – the largest number of deaths reported to date. CDC also published data estimating the number of lives lost due to excessive alcohol use – nearly 178,000 each year – an often-overlooked dimension of our nation’s substance use challenges.

May 6, 2024, 08:28 by Molly McGrath

ASAM signed a letter spearheaded by Mental Health Liaison Group, sent to U.S. Senators Tina Smith and Debbie Stabenow, and U.S. Representatives Paul Tonko, Brian Fitzpatrick, and David Trone, urging support of the Medicaid Bump Act of 2024 (H.R. 4892/S. 3921), which would incentivize states to expand coverage of mental health and substance use disorder (MH/SUD) services by providing a corresponding increase in the Federal Medical Assistance Percentage (FMAP) matching rate to 90 percent.